Agnès Fournier
Fournier, Agnès
VIAF ID: 195100307 (Personal)
Permalink: http://viaf.org/viaf/195100307
Preferred Forms
-
100 0 _ ‡a Agnès Fournier
-
100 1 _ ‡a Fournier, Agnès
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: The EPIC study. |
![]() |
Association between melanocytic nevi and risk of breast diseases: The French E3N prospective cohort |
![]() |
Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults |
![]() |
Associations Between Migraine and Type 2 Diabetes in Women: Findings From the E3N Cohort Study |
![]() |
Asthma Medication Ratio Phenotypes in Elderly Women. |
![]() |
Characteristics and recent evolution of menopausal hormone therapy use in a cohort of Swedish women |
![]() |
[Did the decrease in use of menopausal hormone therapy induce a decrease in the incidence of breast cancer in France |
![]() |
Differential dietary nutrient intake according to hormone replacement therapy use: an underestimated confounding factor in epidemiologic studies? |
![]() |
[Drugs and cancer risk: the example of THM] |
![]() ![]() |
Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort |
![]() |
EPIC-Heart: the cardiovascular component of a prospective study of nutritional, lifestyle and biological factors in 520,000 middle-aged participants from 10 European countries. |
![]() |
Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France |
![]() |
The impact of historical breastfeeding practices on the incidence of cancer in France in 2015. |
![]() |
The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort |
![]() |
Long-Term Exposure to Ambient Air Pollution and Incidence of Postmenopausal Breast Cancer in 15 European Cohorts within the ESCAPE Project. |
![]() |
Mediation analysis of the alcohol-postmenopausal breast cancer relationship by sex hormones in the EPIC cohort |
![]() |
Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l'Education Nationale (E3N) cohort |
![]() |
Menopausal hormone therapy and risk of cholecystectomy: a prospective study based on the French E3N cohort |
![]() |
[Menopause hormonal treatment and risk of breast cancer: comments on the results of the Million Women Study] |
![]() |
Menstrual factors, reproductive history, hormone use, and Urothelial carcinoma risk: A prospective study in the EPIC cohort |
![]() |
Multimorbidity-medications and poor asthma prognosis. |
![]() |
Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort Consortium |
![]() |
Personal history of endometriosis and risk of cutaneous melanoma in a large prospective cohort of French women |
![]() |
Physical activity, sex steroid, and growth factor concentrations in pre- and post-menopausal women: a cross-sectional study within the EPIC cohort |
![]() |
Postmenopausal hormone therapy initiation before and after the Women's Health Initiative in two French cohorts |
![]() |
Predicting Circulating CA125 Levels among Healthy Premenopausal Women |
![]() |
Progestagens use before menopause and breast cancer risk according to histology and hormone receptors |
![]() |
Prospective analysis of circulating metabolites and breast cancer in EPIC |
![]() |
Prospective Study on Physical Activity and Risk of In Situ Breast Cancer |
![]() |
Relation entre prise de traitements hormonaux substitutifs de la ménopause et risque de cancer du sein dans la cohorte E3N |
![]() |
Reproductive and Lifestyle Factors and Circulating sRANKL and OPG Concentrations in Women: Results from the EPIC Cohort |
![]() |
Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study |
![]() |
Response to the letter by Deltour et al |
![]() |
Risk of onset of menopausal symptoms in periods surrounding menopause |
![]() |
Risk of osteoporotic fractures after discontinuation of menopausal hormone therapy: results from the E3N cohort |
![]() |
Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts |
![]() |
Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). |
![]() |
Should transdermal rather than oral estrogens be used in menopausal hormone therapy? A review |
![]() |
[THM: many unknowns before asserting that the balance is in favor of a profit!] |
![]() |
Trajectories of Depressive Symptoms Before Diagnosis of Dementia: A 28-Year Follow-up Study. |
![]() |
Tumor-associated auto-antibodies as early detection markers for ovarian cancer? A prospective evaluation. |
![]() |
Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study |
![]() |
Unsuspected consequences of the adolescent overweight epidemic |
![]() |
Use of benzodiazepines and cardiovascular mortality in a cohort of women aged over 50 years |
![]() |
Use of nonsteroidal anti-inflammatory drugs and breast cancer risk in a prospective cohort of postmenopausal women |
![]() |
Vitamin C supplement intake and postmenopausal breast cancer risk: interaction with dietary vitamin C. |
![]() |